CN Stock MarketDetailed Quotes
003017 Zhejiang Dayang Biotech Group
- 18.86
- -0.34-1.77%
Not Open Nov 15 15:00 CST
1.58BMarket Cap25.94P/E (TTM)
19.42High18.83Low13.37KlotVolume19.00Open19.20Pre Close25.59MTurnover1.98%Turnover Ratio31.70P/E (Static)84.00MShares25.5052wk High1.54P/B1.27BFloat Cap11.4752wk Low21.12Limit Up67.59MShs Float42.94Historical High17.28Limit Down3.07%Amplitude11.47Historical Low0.45Dividend TTM19.14Avg Price6.12KlotAsk2.39%Div YieldTTM100Lot Size6.63KlotBid
Zhejiang Dayang Biotech Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 3.04%626.56M | -7.97%347.85M | -5.24%170.46M | -8.47%830.25M | -6.24%608.06M | -9.26%377.98M | 19.41%179.89M | 43.23%907.12M | 19.06%648.5M | 18.57%416.53M |
| Refunds of taxes and levies | -46.07%9.33M | -5.41%5.74M | -29.09%3.49M | -63.21%13.47M | -49.34%17.29M | -78.75%6.07M | -31.94%4.92M | 74.89%36.61M | 24.58%34.13M | 344.89%28.55M |
| Cash received relating to other operating activities | 57.00%17.41M | -29.15%8.44M | -4.00%3.17M | 8.60%31.23M | -54.91%11.09M | -16.56%11.92M | 232.86%3.3M | 3.55%28.76M | 110.05%24.59M | -24.58%14.28M |
| Cash inflows from operating activities | 2.65%653.3M | -8.57%362.03M | -5.84%177.12M | -10.03%874.96M | -10.01%636.44M | -13.80%395.96M | 18.41%188.11M | 42.58%972.49M | 21.14%707.23M | 21.97%459.37M |
| Goods services cash paid | 17.50%453.59M | -1.12%234.85M | -14.66%123.78M | -30.26%486.26M | -20.80%386.04M | -39.75%237.5M | -3.39%145.04M | 31.66%697.21M | 31.31%487.45M | 50.07%394.17M |
| Staff behalf paid | 1.27%89.1M | 0.99%60.5M | 2.07%28.45M | 9.57%117.74M | 14.02%87.98M | 18.76%59.91M | 16.47%27.87M | -4.36%107.46M | 0.53%77.16M | 2.83%50.44M |
| All taxes paid | -27.22%28.55M | -50.43%15.87M | -59.05%9.87M | 21.22%44.52M | 37.65%39.22M | 67.81%32.01M | 195.77%24.09M | 12.72%36.73M | 10.22%28.5M | 5.68%19.07M |
| Cash paid relating to other operating activities | -45.68%28.51M | -22.86%17.07M | 11.48%14.85M | 12.27%44.01M | -1.48%52.49M | -12.49%22.12M | -13.16%13.32M | -8.26%39.21M | 8.80%53.27M | -14.10%25.28M |
| Cash outflows from operating activities | 6.01%599.75M | -6.62%328.28M | -15.87%176.95M | -21.36%692.53M | -12.48%565.73M | -28.11%351.54M | 6.47%210.32M | 22.78%880.6M | 23.64%646.38M | 36.13%488.97M |
| Net cash flows from operating activities | -24.27%53.55M | -24.04%33.75M | 100.79%176.29K | 98.53%182.42M | 16.20%70.71M | 250.07%44.42M | 42.57%-22.21M | 361.37%91.89M | -0.29%60.85M | -269.67%-29.6M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -93.27%40M | -97.23%9M | ---- | -47.66%530M | -33.91%594.64M | -52.25%325M | -53.88%174.64M | -12.42%1.01B | 11.71%899.68M | 40.10%680.68M |
| Cash received from returns on investments | -80.77%973.99K | -74.23%954.94K | -88.79%182.86K | -35.13%5.45M | -14.08%5.07M | 21.64%3.71M | -6.75%1.63M | -27.77%8.4M | -32.40%5.9M | -51.59%3.05M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 86.77%1.78M | 343.57%1.69M | 62.16%510K | -80.08%1.36M | --950.49K | --379.93K | --314.51K | 845.79%6.85M | ---- | ---- |
| Cash inflows from investing activities | -92.88%42.75M | -96.46%11.64M | -99.61%692.86K | -47.78%536.81M | -33.67%600.65M | -51.87%329.09M | -53.58%176.58M | -12.11%1.03B | 11.19%905.58M | 38.83%683.73M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -15.27%45.59M | 1.85%48.63M | 12.13%27.25M | -0.98%103.63M | -33.68%53.81M | -31.85%47.74M | -42.52%24.3M | 12.01%104.65M | -28.26%81.13M | 30.24%70.06M |
| Cash paid to acquire investments | -54.26%153M | -73.79%45M | ---- | -72.11%288.1M | -64.46%334.52M | -72.65%171.71M | -48.12%201.13M | -3.17%1.03B | 24.77%941.37M | 44.38%627.74M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.6M | --2.37M |
| Cash outflows from investing activities | -48.86%198.59M | -57.33%93.63M | -87.91%27.25M | -65.57%391.73M | -62.12%388.33M | -68.66%219.45M | -47.68%225.43M | -1.97%1.14B | 18.15%1.03B | 43.31%700.17M |
| Net cash flows from investing activities | -173.40%-155.85M | -174.78%-81.99M | 45.63%-26.56M | 232.04%145.08M | 277.63%212.32M | 766.64%109.64M | 3.12%-48.85M | -1,335.83%-109.88M | -124.91%-119.53M | -519.56%-16.45M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 33.65%544.97M | 30.14%372.51M | -1.41%129.04M | -6.67%519.38M | -19.44%407.74M | -24.77%286.24M | 118.14%130.88M | 301.35%556.51M | --506.16M | --380.51M |
| Cash received relating to other financing activities | --33.41M | --20.72M | ---- | ---- | ---- | --0 | ---- | --42.36M | --42.37M | ---- |
| Cash inflows from financing activities | 41.85%578.38M | 37.38%393.23M | -1.41%129.04M | -13.27%519.38M | -25.67%407.74M | -24.77%286.24M | 118.14%130.88M | 331.91%598.87M | --548.53M | --380.51M |
| Borrowing repayment | 34.13%455.53M | 48.47%312.53M | 61.58%145.27M | 21.49%551.5M | -24.76%339.62M | -21.95%210.5M | 199.69%89.91M | 4,411.15%453.95M | --451.38M | --269.7M |
| Dividend interest payment | 187.09%45.13M | -72.07%4.05M | 14.77%2.52M | 9.08%42.61M | -59.11%15.72M | 537.46%14.52M | 77.07%2.19M | 1.97%39.06M | 1.38%38.44M | -93.42%2.28M |
| Cash payments relating to other financing activities | --48.45M | 9,073.42%41.21M | --37M | -98.94%943.3K | ---- | -99.49%449.19K | ---- | 9,857.71%88.99M | --89.77M | --88.53M |
| Cash outflows from financing activities | 54.53%549.1M | 58.69%357.79M | 100.64%184.79M | 2.24%595.05M | -38.69%355.34M | -37.46%225.47M | 75.49%92.1M | 1,081.44%582M | 1,428.61%579.59M | 941.00%360.51M |
| Net cash flows from financing activities | -44.14%29.28M | -41.69%35.44M | -243.73%-55.75M | -548.56%-75.68M | 268.71%52.41M | 203.90%60.77M | 415.89%38.79M | -81.13%16.87M | 18.08%-31.06M | 157.75%20M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 62.58%478.44K | 144.56%848.15K | 167.58%456.51K | 89.49%-101.36K | -83.71%294.29K | -57.84%346.8K | -486.45%-675.51K | -25,419.62%-964.46K | 67,211.21%1.81M | 1,732.32%822.63K |
| Net increase in cash and cash equivalents | -121.61%-72.54M | -105.56%-11.96M | -147.89%-81.67M | 12,148.88%251.73M | 481.79%335.73M | 952.92%215.18M | 59.67%-32.95M | -103.31%-2.09M | -192.80%-87.94M | -89.49%-25.23M |
| Add:Begin period cash and cash equivalents | 190.99%381.52M | 193.95%381.52M | 193.95%381.52M | -1.58%129.79M | -0.59%131.11M | -1.58%129.79M | -1.58%129.79M | 91.81%131.88M | 91.81%131.88M | 91.81%131.88M |
| End period cash equivalent | -33.81%308.98M | 7.13%369.57M | 209.61%299.85M | 193.95%381.52M | 962.28%466.84M | 223.45%344.98M | 92.96%96.85M | -1.58%129.79M | 13.49%43.95M | 92.37%106.65M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data